Robin Jones to Administration, Oral
This is a "connection" page, showing publications Robin Jones has written about Administration, Oral.
Connection Strength
0.160
-
Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumors. Clin Cancer Res. 2015 Feb 15; 21(4):693-700.
Score: 0.116
-
A Timely Oral Option: Single-Agent Vinorelbine in Desmoid Tumors. Oncologist. 2020 12; 25(12):e2013-e2016.
Score: 0.044